Neutra Corp (OTC: NTRR), a company dedicated to advancing life sciences, has executed a Letter of Intent (LOI) to acquire CuraConnector.com, Inc. in stock for stock transaction, marking a strategic ...

Exact Sciences has launched its new "Cologuard Plus" test. This test is gaining attention as the most accurate non-invasive ...

The updated stool test for colon cancer finds more cancers and has fewer false positives, meaning fewer people need follow-up ...

Exact Sciences (EXAS) announced the launch of Cologuard Plus, which it calls “the most accurate noninvasive colorectal cancer screening test ...

Cologuard is getting an upgrade after 10 years on the market, as Exact Sciences starts to roll out the new version of its ...

The equity portion of the abrdn World Healthcare Fund fell (gross) but outperformed its custom benchmark over Q4 2024. Click ...

Guggenheim analyst Subbu Nambi lowered the firm’s price target on Exact Sciences (EXAS) to $60 from $73 and keeps a Buy rating on the shares.

Learn more about whether Alvotech or Exact Sciences Corporation is a better investment based on AAII's A+ Investor grades, ...

Learn more about whether Alvotech or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which ...

Braidwood oral arguments are set for April 21. A policy expert says many states will maintain the current standards, even if ...

Exact Sciences Corporation’s EXAS investment in high-return pipeline opportunities with significant patient impacts should drive growth in the upcoming quarter. Additionally, the company is advancing ...